Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Dec 16 2022

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-16-2022-1

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call

Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 16-Dec-2022 titled Aurigene Oncology Limited,, a wholly owned subsidiary of the Company, reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Earlier from Dr. Reddy's Laboratories

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases